Stock Taper
SCREENER COMPARE ANY 2 STOCKS
LFCR
LIFECORE BIOMEDICAL, INC.
NASDAQ
$4.54
▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$170.29 M
52w High$8.98
52w Low$3.63
Dividend Yield—
Frequency—
P/E-4.24
Volume132.04K
Shares Out.37.51M

COMPANY

LEADERSHIP

Paul Josephs
CHIEF EXECUTIVE
Paul Josephs

COMPENSATION 2026

Salary$505,582
Stock Awards$1,856,250
Incentive Plan Pay$38,494
All Other Comp.$91,087
Total$2,491,413

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 15, 1996
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
382

PRICE TARGET

Target High$6.50
Target Low$6.50
Target Median$6.50
Target Consensus$6.50

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$25.57M
NOV
3
TUE

PRICE

$4.54 ▲ UP 0.00% (+$0.00)
$4.50$4.55$4.60$4.659:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM4.54

About Lifecore Biomedical, Inc.

https://www.lifecore.com ↗

Lifecore Biomedical, Inc. is a global contract manufacturer specializing in pharmaceutical-grade sodium hyaluronate products and offering development, validation, and manufacturing services, along with food processing through its Curation Foods se...

INDUSTRY

Drug Manufacturers - Specialty & Generic

A SERVICE LIFECORE BIOMEDICAL, INC. IS KNOWN FOR

Aseptic Fill-Finish and CDMO Services

Lifecore Biomedical is a CDMO specializing in sterile injectable development, aseptic filling, and packaging for biopharma companies, with expanded capacity through a recent high-speed isolator filler investment.

COMPETITORS

COMPETITOR
ABBV COMPARE
BAX COMPARE
TMO COMPARE

Revenue by Geography

MapREGIONQ2-2023Q3-2023
SWITZERLAND$4M $6.8M ▲
AUSTRALIA— $1.1M
IRELAND$1M $1.1M ▲
CANADA$2.6M $700K ▼
CZECHIA$1M $700K ▼
All Other Countries$500K $200K ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
21
LISTED HERE
4
RANKED BY POSITION SIZE
VTS.AX
0.00% · 822.1K
XSU.TO
0.00% · 720.0K
RSSL
0.00% · 13.4K
BIB
0.01% · 1.3K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
65.23%
HOLDERS
146
TOP 12 OF 146 · RANKED BY POSITION SIZE
Wynnefield Capital Inc
4.7M sh · $24.69M
Legion Partners Asset Management, LLC
4.5M sh · $23.42M
Greenhaven Road Investment Management, L.P.
3.7M sh · $27.19M
325 Capital LLC
2.9M sh · $15.2M
Blackrock, Inc.
2.0M sh · $10.57M
Vanguard Group Inc
1.7M sh · $13.69M
Blackrock Inc.
1.5M sh · $7.45M
Geode Capital Management, LLC
855.5K sh · $4.49M
Grizzlyrock Capital, LLC
827.5K sh · $3.08M
Morgan Stanley
769.4K sh · $4.04M
State Street Corp
668.0K sh · $3.51M
Quinn Opportunity Partners LLC
453.5K sh · $2.38M

RATINGS SNAPSHOT

Overall rating: D+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

★
DIRECTOR, 10 PERCENT OWNER:
Kiper Christopher S
Purchase · 25.9K shares
2026-06-04
★
DIRECTOR
OBUS NELSON
Purchase · 25.9K shares
2026-06-04
★
DIRECTOR
Aryeh Jason
Purchase · 25.9K shares
2026-06-04
★
DIRECTOR
Schechter Joshua
Purchase · 25.9K shares
2026-06-04

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OUTPERFORM 1
1 GRADES IN THE LAST 12 MONTHS
Barrington Research OUTPERFORM

SECTORS PEERS

PEERPRICE
ACHV$8.10COMPARE
SGHT$8.55COMPARE
CGC$1.00COMPARE
TKNO$7.12COMPARE
BIOA$9.65COMPARE
ACB$4.01COMPARE
PRQR$2.29COMPARE
CVRX$2.95COMPARE